The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology
Kaye, Alan D
AffiliationUniv Arizona, Dept Anesthesiol, Coll Med Phoenix
MetadataShow full item record
CitationPerchiazzi, G., Pellegrini, M., Chiodaroli, E., Urits, I., Kaye, A. D., Viswanath, O., ... & Puntillo, F. (2020). The use of positive end expiratory pressure in patients affected by COVID-19: Time to reconsider the relation between morphology and physiology. Best Practice & Research Clinical Anaesthesiology.
RightsCopyright © 2020 The Authors. Published by Elsevier Ltd. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at firstname.lastname@example.org.
AbstractCoronavirus disease 2019 (COVID-19) is a new disease with different phases that can be catastrophic for subpopulations of patients with cardiovascular and pulmonary disease states at baseline. Appreciation for these different phases and treatment modalities, including manipulation of ventilatory settings and therapeutics, has made it a less lethal disease than when it emerged earlier this year. Different aspects of the disease are still largely unknown. However, laboratory investigation and clinical course of the COVID-19 show that this new disease is not a typical acute respiratory distress syndrome process, especially during the first phase. For this reason, the best strategy to be applied is to treat differently the single phases and to support the single functions of the failing organs as they appear. (C) 2020 The Authors. Published by Elsevier Ltd.
NoteOpen access article
VersionFinal published version
Except where otherwise noted, this item's license is described as Copyright © 2020 The Authors. Published by Elsevier Ltd. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
- The ARDSnet protocol may be detrimental in COVID-19.
- Authors: Tsolaki V, Zakynthinos GE, Makris D
- Issue date: 2020 Jun 16
- Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.
- Authors: Grieco DL, Bongiovanni F, Chen L, Menga LS, Cutuli SL, Pintaudi G, Carelli S, Michi T, Torrini F, Lombardi G, Anzellotti GM, De Pascale G, Urbani A, Bocci MG, Tanzarella ES, Bello G, Dell'Anna AM, Maggiore SM, Brochard L, Antonelli M
- Issue date: 2020 Aug 28
- Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study.
- Authors: Angulo M, Beltramelli R, Amarelle L, Alzugaray P, Briva A, Santos C
- Issue date: 2020 Nov
- Flow controlled ventilation in Acute Respiratory Distress Syndrome associated with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
- Authors: Roehrig S, Ait Hssain A, Shallik NAH, Elsaid IMA, Mustafa SF, Smain OAM, Molokhia AA, Lance MD
- Issue date: 2020 Sep 11
- Advanced respiratory monitoring in COVID-19 patients: use less PEEP!
- Authors: Roesthuis L, van den Berg M, van der Hoeven H
- Issue date: 2020 May 15